Article
Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
Antimicrobial agents and chemotherapy - 1 Aug 2014
Eziefula Alice C, Pett Helmi, Grignard Lynn, Opus Salome, Kiggundu Moses, Kamya Moses R, Yeung Shunmay, Staedke Sarah G, Bousema Teun, Drakeley Chris
Abstract excerpt
Glucose-6-phosphate dehydrogenase (G6PD) enzyme function and genotype were determined in Ugandan children with uncomplicated falciparum malaria enrolled in a primaquine trial after exclusion of severe G6PD deficiency by fluorescent spot test. G6PD A- heterozygotes and hemizygotes/homozygotes experienced dose-dependent lower hemoglobin concentrations after treatment. No severe anemia was observed.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
